Quince Therapeutics
QNCX
QNCX
45 hedge funds and large institutions have $12M invested in Quince Therapeutics in 2023 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 6 increasing their positions, 14 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
38% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 8
57% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 14
Holders
45
Holding in Top 10
–
Calls
$360K
Puts
$6K
Top Buyers
| 1 | +$5.65M | |
| 2 | +$118K | |
| 3 | +$62.2K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$33.4K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$18.9K |
Top Sellers
| 1 | -$543K | |
| 2 | -$531K | |
| 3 | -$390K | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$167K |
| 5 |
ECG
EPIQ Capital Group
San Francisco,
California
|
-$152K |